MA RADV Audit Coding Is Fundamentally Different
Many plans underestimate how different an MA RADV audit really is from standard retrospective coding, particularly the contract-level (Con-RADV) review CMS now requires. That gap is where audit risk grows. The methodologies, documentation standards, and coder skill sets required are not interchangeable.
MA RADV Audit Sample Sizes Range from 35 to 200 Enrollees Per Contract
CMS assigns sample sizes based on contract size. The top 10 contracts receive 200 sampled enrollees; the next tier receives 100, then 50, with smaller contracts receiving 35. In PY2019, all contracts received 35. For larger plans, the jump to 200 represents a nearly 6x increase — hundreds of charts, thousands of dates of service, and surge demand that internal teams are rarely staffed to absorb alongside routine risk adjustment workflows.
Six Payment Years of Overlapping Pressure.
CMS has published an official MA RADV audit schedule covering six payment years — PY2020 through PY2025 — launching approximately every two to three months from March 2026 through spring 2027. CMS initiated PY2023 on November 13, 2026, selecting 582 contracts. With PY2021 extended to December 18 and PY2024 open until February 5, most audited plans will be running three Con-RADV audits at once from December 1, alongside ACA HHS-RADV and retrospective coding cycles. Like PY2020, PY2021 and PY2024, PY2023 has been designed by CMS to calculate extrapolated overpayments — this time using the 2020 (V24) CMS-HCC model — though whether extrapolation will actually be collected remains unresolved: the 2023 extrapolation rule was vacated by a federal district court in 2025, and CMS's appeal is now docketed with the Fifth Circuit.
MA RADV only. ACA HHS-RADV and HEDIS cycles also running. All dates per the official CMS RADV Audit Schedule and the PY2023 and PY2024 Audit Methods and Instructions. Updated November 17, 2026. Subject to change.
Compiled by ATTAC Consulting Group / Validira.
PY2022 and PY2025 are scheduled to initiate in 2027 — non-sequentially, per CMS data readiness. All of it running alongside ACA HHS-RADV and routine coding cycles. Validira was built for exactly this pace.
Proven at Scale
Validira has supported MA RADV audit engagements across the country since the program's earliest cycles. These numbers reflect what we deliver.
Built for MA RADV. Ready When You Are.
Validira from ATTAC Consulting Group is a specialized MA Con-RADV coding and audit management solution, not a generic coding shop pressed into audit service. We've been doing this for nearly a decade, and our entire infrastructure is designed for the complexity that MA RADV demands.
ATTAC has been a game-changer for us. They are agile, responsive, and willing to bend over backwards to provide us with what we need. Compared to past audit partners, the experience has been night and day. We only wish we had brought them on sooner.
Frequently Asked Questions
What your Risk Adjustment team needs to know about navigating MA Con-RADV audits.
CMS sends an Audit Notice to the contract's CEO, CFO, COO, and Medicare Compliance Officer. The Enrollee Data List (EDL) is then made available in CDAT, followed by the opening of the medical record submission window. For PY2024, the submission window runs September 18, 2026 through February 5, 2027. For PY2023, the EDL is available November 30, 2026 and the submission window runs December 4, 2026 through April 23, 2027 at 11:59pm EST.
CMS assigns sample sizes across four strata based on contract size. The top 10 contracts by sampling frame receive 200 enrollees; the next group receives 100, then 50, with the smallest contracts receiving 35. In PY2019, all contracts received 35. Plans should check their EDL in CDAT to confirm their specific sample size for each audited payment year.
MA Con-RADV HCC validation coding requires documenting every HCC on every date of service within a record, ranking documentation quality per HCC, and evaluating which records are strongest for submission. CMS allows a maximum of two medical records per audited HCC. Standard retrospective coding captures an HCC once on a single date of service — making Con-RADV coding significantly more specialized and time-intensive.
CMS has published a schedule covering six payment years — PY2020 through PY2025 — running from March 2026 into spring 2027. The order is not sequential: PY2024 initiated before PY2023, with PY2022 and PY2025 to follow in 2027. From December 1, 2026, most audited plans will be managing three Con-RADV audits simultaneously: the final weeks of PY2021 (extended to December 18, 2026), the start of PY2023 and active PY2024 work, on top of ACA HHS-RADV and routine risk adjustment cycles. The PY2020 submission window has closed. All dates are per the official CMS RADV Audit Schedule and subject to change.
CMS initiated the PY2023 MA contract-specific RADV audit on November 13, 2026, selecting 582 contracts. The audit applies the 2020 (V24) CMS-HCC risk adjustment model to diagnoses from the January 1 through December 31, 2022 data collection year, using the same four-strata sample sizes of 35, 50, 100, or 200 enrollees depending on contract size. The Enrollee Data List becomes available in CDAT on November 30, 2026; the medical record submission window opens December 4, 2026 and closes April 23, 2027 at 11:59pm EST; and the Hardship Exception Request deadline is May 7, 2027 at 11:59pm EST. CMS has designed PY2023 to calculate extrapolated overpayments, pending its final decision and the outcome of ongoing litigation.
CMS initiated the PY2024 MA contract-specific RADV audit on August 28, 2026, applying the 2024 (V28) CMS-HCC risk adjustment model to diagnoses from the January 1 through December 31, 2023 data collection year. As in prior cycles, CMS drew its sample from enrollees ranked in the top quartile of its improper payment prediction models, using the same four-strata sample sizes of 35, 50, 100, or 200 enrollees depending on contract size. The Enrollee Data List becomes available in CDAT on September 11, 2026, the medical record submission window opens September 18, 2026 and closes February 5, 2027 at 11:59pm EST, and the Hardship Exception Request deadline is February 19, 2027. Like PY2021, PY2024 is designed to support extrapolated overpayment recovery, pending CMS's final decision and the outcome of ongoing litigation.
Validira provides end-to-end MA RADV support: HCC validation coding via an NLP and AI-enabled platform, medical record retrieval through our partner network, RADV Cycle Management Reporting with 24/7 portal access, documentation strength ranking, coding quality assurance at 10% minimum on every chart, and dedicated audit management with weekly status updates throughout the engagement.
Validira maintains pre-audit readiness so that upon CMS notification, the team can begin receiving data and mobilizing coding within days, not weeks. Pre-configured data exchange pathways, portal access, and coder training protocols are already in place — no ramp-up delay on our end when the clock is running.
CMS has not yet decided for PY2020, PY2021, PY2024, or PY2023. All four audits are designed to support extrapolated overpayment calculations, but CMS will notify plans of its final decision later in each audit cycle. The 2023 extrapolation rule was vacated by a federal district court in 2025 (Humana Inc. v. Becerra, 801 F. Supp. 3d 624 (N.D. Tex. 2025)), and CMS's appeal is now docketed with the Fifth Circuit (No. 25-11293), adding further legal uncertainty.
No. CMS's PY2023 Audit Methods and Instructions state that a change of ownership (CHOW) does not exclude an MA organization from an audit. Plans that have merged, been acquired, or consolidated contracts since the audited payment year should confirm who owns the response, where the records live, and who has CDAT access well before the submission window opens.
CMS uses a risk-based approach, applying predictive analytics to identify contracts where enrollees are most likely to have unsupported diagnoses. Enrollees ranked in the top quartile of CMS's improper payment prediction models are prioritized for sampling. Selection is also informed by results from past CMS and OIG audits.
MA organizations have appeal rights under 42 CFR 422.311(c). Plans may appeal medical record review determinations and payment error calculations within the timeframe specified in the Audit Report Package. Validira's coding SMEs can support plans in preparing and evaluating appeals.
PY2024: EDL available in CDAT September 11, 2026. Submission window September 18, 2026 through February 5, 2027 at 11:59pm EST. Hardship Exception Request deadline February 19, 2027 at 11:59pm EST. PY2023: Audit notices issued November 13, 2026. EDL available in CDAT November 30, 2026. Submission window December 4, 2026 through April 23, 2027 at 11:59pm EST. Hardship Exception Request deadline May 7, 2027 at 11:59pm EST. PY2021: CMS extended the submission deadline to December 18, 2026 and the Hardship Exception Request deadline to January 8, 2027. Recently closed: PY2020's submission window closed August 28, 2026. PY2022 is scheduled to initiate in January–February 2027 and PY2025 in April–May 2027, per the CMS RADV Audit Schedule.
Download the Validira MA RADV Overview
A two-page summary of what Validira brings to your audit, from day one through submission.
Download the 2-Pager (PDF) →CMS is ready. Validira is ready. Are you?
The audit calendar is set. Our coding teams are standing by. The only variable is whether your plan has the right partner in place before notices arrive.

